Major depression is an illness that can be treated. It stands as
one of the most common psychiatric disorders, and affects about one in six people.
The World Health Organization ranks depression as one of the top causes of suffering
and disability world wide, yet effective treatment is available.
Our research program is focused on improving treatments for depression.
Many of our projects examine how depression affects brain function, how brain activity changes when a person is
being treated, and how this information might be used to provide more effective care for people
with depression. Additionally, we are involved with developing and evaluating new treatments for depression.
Our clinical research projects are currently open for enrollment.
Please call us at 310-825-3351 to talk with someone
about participating, or for more information, please look at the PDF files of our flyers for:
- Synchronized TMS (sTMS), a new form of magnetic stimulation
for depression which has not responded to a trial of medication (age 22-65) (experimental treatment)
- Project PRISE-MD, using FDA-approved antidepressant
medications and new brain biomarkers in adults (age 21-75)
- Project BOLD, using an FDA-approved antidepressant
medication and our brain activity biomarker in older adults (age 62 and up)
- Adolescent Depression Project, using an FDA-approved antidepressant
medication, and our brain activity biomarker in adolescents (age 12-22)
- Studies of Trigeminal Nerve Stimulation (TNS) (experimental treatment, invented at UCLA):
